The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Hematopoietic stem cell transplant for adults with mixed phenotypic acute leukemia.
 
Jennifer Jing Huang
No Relationships to Disclose
 
Jacob Appelbaum
No Relationships to Disclose
 
Kathryn Russell
No Relationships to Disclose
 
Carole Shaw
No Relationships to Disclose
 
Ashley Eckel
Employment - Hematologics
Patents, Royalties, Other Intellectual Property - 20150359815 (Inst)
(OPTIONAL) Uncompensated Relationships - University of Washington Medical Center
 
Xueyan Chen
No Relationships to Disclose
 
Rutu Vyas
No Relationships to Disclose
 
Paul Hendrie
No Relationships to Disclose
 
Anna B. Halpern
Consulting or Advisory Role - Abbvie; Agios; Notable labs
Research Funding - Bayer (Inst); disc medicine (Inst); Gilead/Forty Seven (Inst); Imago Pharma (Inst); Incyte (Inst); Jazz Pharmaceuticals (Inst); Karyopharm Therapeutics (Inst)
 
Raya Mawad
No Relationships to Disclose
 
Ryan Daniel Cassaday
Employment - Seagen (I)
Stock and Other Ownership Interests - Seagen (I)
Honoraria - Kite, a Gilead company; Pfizer
Consulting or Advisory Role - Amgen; Autolus; Jazz Pharmaceuticals; Kite/Gilead; Pfizer
Research Funding - Amgen (Inst); Incyte (Inst); Kite, a Gilead company (Inst); Pfizer; SERVIER (Inst); Vanda Pharmaceuticals
Travel, Accommodations, Expenses - Kite, a Gilead company
Other Relationship - Autolus; Pepromene
 
Roland B. Walter
Stock and Other Ownership Interests - Amphivena Therapeutics
Consulting or Advisory Role - Abbvie; Adicet Bio; BerGenBio; BiolineRx; Bristol-Myers Squibb/Celgene/Juno; Genentech; GlaxoSmithKline; Janssen; Jazz Pharmaceuticals; Kronos; Kura Oncology; Orum Therapeutics; Pfizer; Stemline Therapeutics
Research Funding - Amgen (Inst); Aptevo Therapeutics; Arog (Inst); Celgene; Immunogen (Inst); Janssen Research & Development (Inst); Jazz Pharmaceuticals (Inst); Kite/Gilead; Kura Oncology; Macrogenics (Inst); Pfizer; Selvita (Inst)
 
Mary-Elizabeth M. Percival
Consulting or Advisory Role - Genentech
Research Funding - Abbvie (Inst); Ascentage Pharma (Inst); Astex Pharmaceuticals (Inst); Biosight (Inst); Cardiff Biotechnology (Inst); Celgene/Bristol-Myers Squibb (Inst); Glycomimetics (Inst); Immunogen (Inst); Oscotec; Pfizer (Inst); Telios (Inst)
 
Cristina Maria Ghiuzeli
Stock and Other Ownership Interests - Pfizer